Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

842
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

400
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
400
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

762
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
762
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

494
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
494
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

1.0K
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical evaluation of different ophthalmic optical coherence tomography devices using a retinal biomimetic phantom].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same author

[Influencing factors and countermeasures of pulse pressure variation in predicting volume responsiveness in patients with acute respiratory distress syndrome].

Zhonghua nei ke za zhi·2022
Same author

Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus.

Scandinavian journal of rheumatology·2015
Same author

Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study.

Current medical research and opinion·2012
Same author

Influence of lifetime hip joint force on the risk of self-reported hip osteoarthritis: a community-based cohort study.

Osteoarthritis and cartilage·2011
Same author

Correlation between the characteristic green emissions and specific defects of ZnO.

Physical chemistry chemical physics : PCCP·2010

Related Experiment Video

Updated: May 1, 2026

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
10:02

Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

Published on: October 3, 2020

3.6K

Asymptomatic hyperuricemia: the case for conservative management.

M H Liang, J F Fries

    Annals of Internal Medicine
    |May 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Managing asymptomatic hyperuricemia is debated. Current evidence suggests risks are low and treatment efficacy is unproven, favoring an expectant approach for gout and kidney disease prevention.

    More Related Videos

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    1.1K
    A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction
    05:34

    A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction

    Published on: July 18, 2025

    634

    Related Experiment Videos

    Last Updated: May 1, 2026

    Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
    10:02

    Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril

    Published on: October 3, 2020

    3.6K
    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    1.1K
    A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction
    05:34

    A Mouse Model to Evaluate the Long-Term Structural and Functional Outcomes after the Reversal of Prolonged Unilateral Ureteric Obstruction

    Published on: July 18, 2025

    634

    Area of Science:

    • Nephrology
    • Rheumatology
    • Internal Medicine

    Background:

    • Asymptomatic hyperuricemia management is controversial.
    • Potential benefits include preventing gouty arthritis, tophaceous gout, and kidney issues.
    • Treatment efficacy and risks are not well-established.

    Purpose of the Study:

    • To review experimental and clinical data on asymptomatic hyperuricemia.
    • To evaluate the risks and benefits of long-term treatment.
    • To provide recommendations for patient management.

    Main Methods:

    • Review of existing experimental and clinical data.
    • Analysis of reported benefits and risks of treatment.
    • Consideration of treatment costs, side effects, and patient compliance.

    Main Results:

    • Risks associated with asymptomatic hyperuricemia appear small or unknown.
    • Long-term treatment efficacy in preventing gout or renal disease is unproved.
    • Costs, risks of drug administration, and compliance issues challenge long-term therapy.

    Conclusions:

    • An expectant approach is recommended for managing asymptomatic hyperuricemia.
    • Current evidence does not support routine long-term treatment.
    • Further research may clarify risks and benefits.